Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dantzig

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
JACC. Cardiovascular Interventions|March 24, 2012
Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion studyInge Wijnbergen, Harold Helmes, Jan Tijssen, et al.
The American Journal of Pathology|October 28, 2003
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cellsJanardhan Sampath, Pandy R Long, Robert L Shepard, et al.
Science (New York, N.Y.)|April 15, 1994
Association of intestinal peptide transport with a protein related to the cadherin superfamilyA H Dantzig, J A Hoskins, L B Tabas, et al.
The Annals of Thoracic Surgery|May 22, 2012
Increased septum wall thickness in patients undergoing aortic valve replacement predicts worse late survivalAlbert H M van Straten, Mohamed A Soliman Hamad, Katinka C H Peels, et al.
Molecular Cancer Therapeutics|December 23, 2011
Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesisGiulio Francia, Yuval Shaked, Kae Hashimoto, et al.
The American Journal of Cardiology|January 2, 2007
Relation of isovolumic times after cardiac resynchronization therapy to improvement in exercise capacityAnnemieke H M Jansen, Kathinka H Peels, Frank Bracke, et al.
International Journal of Cancer|January 5, 2002
A very early induction of major vault protein accompanied by increased drug resistance in U-937 cellsYi Hu, Andrew G Stephen, Jin Cao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 12, 2012
Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinaseJessica A Roseberry Baker, Enaksha R Wickremsinhe, Claire H Li, et al.
Journal of the American College of Cardiology|December 29, 2000
Acute and short-term effects of partial left ventriculectomy in dilated cardiomyopathy: assessment by pressure-volume loopsJ J Schreuder, P Steendijk, F H van der Veen, et al.
Biochemical Pharmacology|March 10, 2004
Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transportersAnne H Dantzig, Robert L Shepard, Susan E Pratt, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
JACC. Cardiovascular Interventions|March 24, 2012
Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion studyInge Wijnbergen, Harold Helmes, Jan Tijssen, et al.
The American Journal of Pathology|October 28, 2003
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cellsJanardhan Sampath, Pandy R Long, Robert L Shepard, et al.
Science (New York, N.Y.)|April 15, 1994
Association of intestinal peptide transport with a protein related to the cadherin superfamilyA H Dantzig, J A Hoskins, L B Tabas, et al.
The Annals of Thoracic Surgery|May 22, 2012
Increased septum wall thickness in patients undergoing aortic valve replacement predicts worse late survivalAlbert H M van Straten, Mohamed A Soliman Hamad, Katinka C H Peels, et al.
Molecular Cancer Therapeutics|December 23, 2011
Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesisGiulio Francia, Yuval Shaked, Kae Hashimoto, et al.
The American Journal of Cardiology|January 2, 2007
Relation of isovolumic times after cardiac resynchronization therapy to improvement in exercise capacityAnnemieke H M Jansen, Kathinka H Peels, Frank Bracke, et al.
International Journal of Cancer|January 5, 2002
A very early induction of major vault protein accompanied by increased drug resistance in U-937 cellsYi Hu, Andrew G Stephen, Jin Cao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 12, 2012
Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinaseJessica A Roseberry Baker, Enaksha R Wickremsinhe, Claire H Li, et al.
Journal of the American College of Cardiology|December 29, 2000
Acute and short-term effects of partial left ventriculectomy in dilated cardiomyopathy: assessment by pressure-volume loopsJ J Schreuder, P Steendijk, F H van der Veen, et al.
Biochemical Pharmacology|March 10, 2004
Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transportersAnne H Dantzig, Robert L Shepard, Susan E Pratt, et al.
Pageof 19